Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Clinical trial NCT01847235 · COMPLETED
Trial details
- NCT number
- NCT01847235
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-09-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.